This abstract provides an in-depth exploration of drug development, from historical perspectives to modern challenges and emerging trends. It begins by tracing the evolution of drug development over centuries, highlighting the pivotal role of pharmacy and regulatory oversight. The abstract emphasizes the multifaceted nature of drug development, involving collaboration across scientific disciplines and various stages, from preclinical to post-market monitoring. The challenges inherent in drug development, such as high costs, lengthy timelines, and regulatory hurdles, are thoroughly examined. Despite these challenges, the abstract underscores the importance of drug development in addressing unmet medical needs and improving public health. Furthermore, the abstract delves into specific aspects of drug development, including preclinical research and discovery, clinical trial methodologies, and successes and challenges in the field. It also discusses emerging trends, such as precision medicine, digitalization, and the role of artificial intelligence and machine learning. Overall, this abstract is providing a comprehensive overview of drug development, highlighting its significance, challenges, and future directions in advancing healthcare.
Parag Chandrakant Patil*1, Harshali Rajendra Patil2, Nilesh Rajendra Patil3, Harshad Shiva Kadam4, Sughosh Upasani5 (Wed,) studied this question.